Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 5/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.39 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.39 |
| ▸ | KDM5C | P41229 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KDM6B | O15054 | 1/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.37 |
| ▸ | KDM5A | P29375 | 5/20 | 0.37 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.36 |
| ▸ | KDM4A | O75164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27738298 | 0.98 | MEN1 (0.42) | LSSPHF8KDM2AKDM5CALDH1A1 | |
| SCHEMBL7866824 | 0.88 | ABCC4 (0.45) | LSSKDM5CALDH1A1ABCC4MAPT | |
| SCHEMBL7864401 | 0.86 | ABCC4 (0.48) | LSSPHF8KDM5CABCC4MAPT | |
| SCHEMBL3199669 | 0.81 | LSS (0.32) | LSS | |
| SCHEMBL3316384 | 0.81 | ALDH1A1 (0.38) | LSSALDH1A1MEN1KMT2A | |
| Butyric Acid SCHEMBL28800929 | 0.81 | FFAR3 (0.54) | PHF8KDM2AKDM5CALDH1A1MEN1 | |
| SCHEMBL3199804 | 0.80 | ITGB3 (0.32) | LSSMEN1KMT2A | |
| SCHEMBL3187141 | 0.80 | ITGB3 (0.32) | LSSMEN1KMT2A | |
| SCHEMBL718216 | 0.78 | KMT2A (0.56) | PHF8KDM2AKDM5CMEN1KMT2A | |
| SCHEMBL461717 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20210283034-A1 | CLEANSING MATERIAL COMPOSITION | AJINOMOTO CO., INC. (JP) | 2021-09-16 | — | — | US | disclosed |
| WO-2020158056-A1 | POLYVINYL ALCOHOL RESIN FILM | 株式会社アイセロ | 2020-08-06 | — | — | WO | disclosed |
| WO-2020116566-A1 | COMPOSITION FOR DETERGENT | 味の素株式会社 | 2020-06-11 | — | — | WO | disclosed |
| US-9803102-B2 | Slip preventing agent for socks | NIPPON ZETTOC CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| CN-105492562-B | Socks slip preventing agent | 日本泽托克株式会社 | 2017-07-21 | — | — | CN | disclosed |
| US-20160272838-A1 | SLIP PREVENTING AGENT FOR SOCKS | NIPPON ZETTOC CO., LTD. (JP) | 2016-09-22 | — | — | US | disclosed |
| CN-105492562-A | Sock slippage inhibitor | NIPPON ZETTOC CO LTD | 2016-04-13 | — | — | CN | disclosed |
| US-8937090-B2 | Parakeratosis inhibitor, pore-shrinking agent and external composition for skin | SHISEIDO COMPANY, LTD. (JP) | 2015-01-20 | — | — | US | disclosed |
| US-20120232111-A1 | Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin | SHISEIDO COMPANY, LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-7608250-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2009-10-27 | — | — | US | disclosed |
| EP-1941861-A1 | WRINKLE-IMPROVING AGENT | Shiseido Company, Limited (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1880711-A1 | PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN | Shiseido Company, Limited (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070284258-A1 | Method For Silver Plating | DAIWA FINE CHEMICALS CO., LTD. (JP) | 2007-12-13 | — | — | US | disclosed |
| US-7166152-B2 | Pretreatment solution for providing catalyst for electroless plating, pretreatment method using the solution, and electroless plated film and/or plated object produced by use of the method | DAIWA FINE CHEMICALS CO., LTD. (JP) | 2007-01-23 | — | — | US | disclosed |
| US-20060029626-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2006-02-09 | — | — | US | disclosed |
| US-20040043153-A1 | Pretreatment solution for providing catalyst for electroless plating, pretreatment method using the solution, and electroless plated film and/or plated object produced by use of the method | DAIWA FINE CHEMICALS CO., LTD. | 2004-03-04 | — | — | US | disclosed |
| US-20030165448-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2003-09-04 | — | — | US | disclosed |
| US-6183545-B1 | MIXTURE CONTAINING A PHOSPHINE | DAIWA FINE CHEMICALS CO., LTD. (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-0895778-A2 | Cosmetic composition | Ajinomoto Co., Inc. (JP) | 1999-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165448-A1 | Cosmetic composition | CUTA, ARGLU1, ASS1 | LSS 2513/4885PHF8 1095/4885KDM2A 1640/4885 |
| US-20060029626-A1 | Cosmetic composition | CUTA, NGLY1, ARG1 | LSS 1639/4885PHF8 1273/4885KDM2A 1669/4885 |
| US-20120232111-A1 | Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin | CUTA, AAAS, NUP160 | LSS 1219/4885PHF8 2425/4885KDM2A 4081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.